AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion

1 hour ago 1
AstraZeneca entered into an exclusive planetary licence statement with China’s Dizal Pharmaceutical for the lung crab treatment.
Read Entire Article
  1. Homepage
  2. Health
  3. AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion

Related

Is your period worsening your ADHD symptoms?

Is your period worsening your ADHD symptoms?

3 hours ago 1
‘Lettuce or Salad Greens’ Identified as Potential Source of Cyclospora Outbreak

‘Lettuce or Salad Greens’ Identified as Potential Source of ...

4 hours ago 1
Workers at an Ebola treatment center in Congo strike over unpaid salaries and bonuses

Workers at an Ebola treatment center in Congo strike over un...

4 hours ago 0

Popular

The World Cup Stood as a Break From U.S. Politics. Then Trump Got Involved.

The World Cup Stood as a Break From U.S. Politics. Then Trum...

6 days ago 19
Former Dallas Cowboys defensive end Kneeland had early stage CTE at time of death

Former Dallas Cowboys defensive end Kneeland had early stage...

6 days ago 19
'Once the curtain is drawn, freedom is absolute': The magic and mystery of old photo booths

'Once the curtain is drawn, freedom is absolute': The magic ...

6 days ago 18
Trump Administration Guts Efforts to Prevent Gun Violence, Suppressing Reports

Trump Administration Guts Efforts to Prevent Gun Violence, S...

6 days ago 17
Mariska Hargitay will host the 78th Primetime Emmy Awards in September

Mariska Hargitay will host the 78th Primetime Emmy Awards in...

6 days ago 17
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved